KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
-
Published:2012-08-29
Issue:
Volume:
Page:
-
ISSN:0022-3050
-
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
-
language:
-
Short-container-title:
您需要登录后可以查看相关数据！